@Article{,
AUTHOR = {Daniel Taussky, Denis Soulières},
TITLE = {Hypofractionated radiotherapy with concomitant sunitinib – is there a radiosensitizing effect?},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {16},
YEAR = {2009},
NUMBER = {2},
PAGES = {4599--4600},
URL = {http://www.techscience.com/CJU/v16n2/62204},
ISSN = {1488-5581},
ABSTRACT = {We present a case of a patient with metastatic renal cell 
cancer (RCC) treated with hypofractionated radiotherapy 
while being treated with sunitinib. He received a single 
dose of 8 Gy of external beam radiation to a metastatic 
mass of several centimeters diameter in the right lateral 
ribs, followed by a second identical dose. Clinically, the 
patient achieved a nearly complete disappearance of the 
mass. We discuss the possible synergy between tyrosine 
kinase receptor inhibitors (TKRIs) and radiotherapy and 
the importance of dose fractionation.},
DOI = {}
}